Annexin A6 is a scaffold for PKCα to promote EGFR inactivation

[1]  S. Moss,et al.  Intracellular Modulation of Signaling Pathways by Annexin A6 Regulates Terminal Differentiation of Chondrocytes* , 2012, The Journal of Biological Chemistry.

[2]  K. Monastyrskaya,et al.  Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly, and function , 2011, Molecular biology of the cell.

[3]  P. Parker,et al.  Site recognition and substrate screens for PKN family proteins. , 2011, The Biochemical journal.

[4]  C. Rentero,et al.  Annexin A6-Linking Ca(2+) signaling with cholesterol transport. , 2011, Biochimica et biophysica acta.

[5]  Chad R. Weisbrod,et al.  Architecture and dynamics of an A-kinase anchoring protein 79 (AKAP79) signaling complex , 2011, Proceedings of the National Academy of Sciences.

[6]  J. Ochieng,et al.  Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions. , 2011, Experimental cell research.

[7]  R. Annan,et al.  MAPK Scaffold IQGAP1 Binds the EGF Receptor and Modulates Its Activation* , 2011, The Journal of Biological Chemistry.

[8]  Jeewon Kim,et al.  Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model , 2010, Oncogene.

[9]  K. Piwocka,et al.  Role of annexin A6 isoforms in catecholamine secretion by PC12 cells: Distinct influence on calcium response , 2010, Journal of cellular biochemistry.

[10]  Y. Yarden,et al.  Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy , 2010, FEBS letters.

[11]  John Kuriyan,et al.  Molecular mechanisms in signal transduction at the membrane , 2010, Nature Structural &Molecular Biology.

[12]  C. Rentero,et al.  Annexin A6-regulator of the EGFR/Ras signalling pathway and cholesterol homeostasis. , 2010, The international journal of biochemistry & cell biology.

[13]  C. Enrich,et al.  Annexins--modulators of EGF receptor signalling and trafficking. , 2009, Cellular signalling.

[14]  K. Monastyrskaya,et al.  Plasma Membrane-associated Annexin A6 Reduces Ca2+ Entry by Stabilizing the Cortical Actin Cytoskeleton* , 2009, The Journal of Biological Chemistry.

[15]  P. Timpson,et al.  Annexin A6 inhibits Ras signalling in breast cancer cells , 2009, Oncogene.

[16]  Pier Paolo Di Fiore,et al.  Endocytosis and Cancer: an ‘Insider’ Network with Dangerous Liaisons , 2008, Traffic.

[17]  S. Steinberg.  Structural basis of protein kinase C isoform function. , 2008, Physiological reviews.

[18]  K. Otulak,et al.  Calcium‐ and pH‐dependent localization of annexin A6 isoforms in Balb/3T3 fibroblasts reflecting their potential participation in vesicular transport , 2008, Journal of cellular biochemistry.

[19]  K. Ferguson,et al.  Structure-based view of epidermal growth factor receptor regulation. , 2008, Annual review of biophysics.

[20]  J. Balsinde,et al.  Annexin A6-induced Inhibition of Cytoplasmic Phospholipase A2 Is Linked to Caveolin-1 Export from the Golgi* , 2008, Journal of Biological Chemistry.

[21]  A. Sorkin,et al.  Endocytosis and intracellular trafficking of ErbBs. , 2008, Experimental cell research.

[22]  P. Timpson,et al.  Protein kinase Cdelta and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactin. , 2008, Molecular biology of the cell.

[23]  Laura A. Sullivan,et al.  Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer , 2007, Cell.

[24]  K. Gaus,et al.  Annexin A6-Induced Alterations in Cholesterol Transport and Caveolin Export from the Golgi Complex , 2007, Traffic.

[25]  I. Ellis,et al.  Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer , 2007, Journal of Clinical Pathology.

[26]  A. Paller,et al.  Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. , 2007, Cancer research.

[27]  P. Timpson,et al.  Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. , 2007, Cancer research.

[28]  E. Rozengurt,et al.  Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists. , 2007, Cellular signalling.

[29]  D. Mochly‐Rosen,et al.  Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. , 2007, Pharmacological research.

[30]  M. Therrien,et al.  KSR and CNK: two scaffolds regulating RAS-mediated RAF activation , 2007, Oncogene.

[31]  K Fenwick,et al.  Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy , 2006, British Journal of Cancer.

[32]  J. Stenvang,et al.  Protein Kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells , 2007, Breast Cancer Research and Treatment.

[33]  R. Piper,et al.  Epidermal Growth Factor Receptor Fate Is Controlled by Hrs Tyrosine Phosphorylation Sites That Regulate Hrs Degradation , 2006, Molecular and Cellular Biology.

[34]  Å. Borg,et al.  Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors , 2006, International journal of cancer.

[35]  W. E. Hughes,et al.  Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells. , 2006, Cellular signalling.

[36]  R. Landgraf,et al.  Signaling through ERBB receptors: multiple layers of diversity and control. , 2006, Cellular signalling.

[37]  D. Schechtman,et al.  δPKC-annexin V interaction; a required step in δPKC translocation and function , 2006 .

[38]  A. Pol,et al.  Involvement of Targeting and Scaffolding Proteins in the Regulation of the EGFR/Ras/MAPK Pathway in Oncogenesis , 2006 .

[39]  M. McNiven,et al.  A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. , 2006, Cancer research.

[40]  D. Schechtman,et al.  Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and function. , 2006, The Journal of biological chemistry.

[41]  W. E. Hughes,et al.  Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity , 2005, Oncogene.

[42]  S. Moss,et al.  Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.

[43]  Jubilee R. Stewart,et al.  Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells , 2005, Molecular Cancer Therapeutics.

[44]  C. O'Brian,et al.  Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells. , 2005, Molecular cancer therapeutics.

[45]  Tianrui Xu,et al.  Phorbol ester‐induced translocation of PKC epsilon to the nucleus in fibroblasts: identification of nuclear PKC epsilon‐associating proteins , 2004, FEBS letters.

[46]  S. Badve,et al.  Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure , 2003, British Journal of Cancer.

[47]  Blagoy Blagoev,et al.  A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.

[48]  R. Kretsinger,et al.  Structural and dynamic changes in human annexin VI induced by a phosphorylation-mimicking mutation, T356D. , 2003, Biochemistry.

[49]  J. Heeren,et al.  Cholesterol Modulates the Membrane Binding and Intracellular Distribution of Annexin 6* , 2002, The Journal of Biological Chemistry.

[50]  A. Kasprzyk,et al.  Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. , 2002, Blood.

[51]  A. Sorkin,et al.  Calmodulin regulates intracellular trafficking of epidermal growth factor receptor and the MAPK signaling pathway. , 2002, Molecular biology of the cell.

[52]  S. Peiró,et al.  Activation of Raf‐1 is defective in annexin 6 overexpressing Chinese hamster ovary cells , 2001, FEBS letters.

[53]  J. Hancock,et al.  Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions , 2001, Oncogene.

[54]  J. Heeren,et al.  Annexin VI Stimulates Endocytosis and Is Involved in the Trafficking of Low Density Lipoprotein to the Prelysosomal Compartment* , 2000, The Journal of Biological Chemistry.

[55]  Y. Yarden,et al.  Threonine Phosphorylation Diverts Internalized Epidermal Growth Factor Receptors from a Degradative Pathway to the Recycling Endosome* , 2000, The Journal of Biological Chemistry.

[56]  P. Parker,et al.  Protein kinase C(alpha) actively downregulates through caveolae-dependent traffic to an endosomal compartment. , 2000, Journal of cell science.

[57]  J. Hancock,et al.  H-ras but Not K-ras Traffics to the Plasma Membrane through the Exocytic Pathway , 2000, Molecular and Cellular Biology.

[58]  A. Newton,et al.  Mechanism of A-kinase-anchoring protein 79 (AKAP79) and protein kinase C interaction. , 1999, The Biochemical journal.

[59]  C. L. Browne,et al.  Activated protein kinase C alpha associates with annexin VI from skeletal muscle. , 1998, The Biochemical journal.

[60]  M. Accomazzo,et al.  Internalization and down-regulation of the prostacyclin receptor in human platelets. , 1997, The Biochemical journal.

[61]  J. Oudinet,et al.  Annexins and protein kinases C. , 1996, Biochimica et biophysica acta.

[62]  S. Moss,et al.  The Ca2+-dependent lipid binding domain of P120GAP mediates protein-protein interactions with Ca2+-dependent membrane-binding proteins. Evidence for a direct interaction between annexin VI and P120GAP. , 1996, The Journal of biological chemistry.

[63]  D. Mochly‐Rosen.  Localization of protein kinases by anchoring proteins: a theme in signal transduction. , 1995, Science.

[64]  A. Hanby,et al.  Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells. , 1995, British Journal of Cancer.

[65]  D. Mochly‐Rosen,et al.  Agonists and antagonists of protein kinase C function, derived from its binding proteins. , 1994, The Journal of biological chemistry.

[66]  P. D. Smith,et al.  Endocytosis occurs independently of annexin VI in human A431 cells , 1994, The Journal of cell biology.

[67]  K. Takishima,et al.  Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase. , 1993, The Journal of biological chemistry.

[68]  S. Bowen,et al.  Constitutive phosphorylation of the epidermal growth factor receptor blocks mitogenic signal transduction. , 1991, The Journal of biological chemistry.

[69]  G. M. Walton,et al.  Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation. , 1990, Journal of Biological Chemistry.

[70]  R. Davis,et al.  Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation. , 1990, The Journal of biological chemistry.

[71]  H. Fujiki,et al.  Phosphorylation at threonine-654 is not required for negative regulation of the epidermal growth factor receptor by non-phorbol tumor promoters. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[72]  A. Ullrich,et al.  Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor , 1988, Molecular and cellular biology.

[73]  J. Cooper,et al.  Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation. , 1986, The Journal of biological chemistry.

[74]  D. Fabbro,et al.  Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. , 1986, Cancer research.

[75]  R. Davis,et al.  Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Jonathan A. Cooper,et al.  Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane , 1984, Nature.

[77]  S. Iwashita,et al.  Epidermal growth factor and potent phorbol tumor promoters induce epidermal growth factor receptor phosphorylation in a similar but distinctively different manner in human epidermoid carcinoma A431 cells. , 1984, The Journal of biological chemistry.